However, as seen in Table 5, our analyses provide strong support for a shortlist that encompasses cerebrovascular disease, cognitive status, self-rated health, and life-satisfaction, in addition to the expected survival advantage among women, non-smokers, and non-carriers of the APOE-e4 allele. This evidence concerns the gene APOE and cerebrovascular disorder.